Sale!

HEXB Gene GM2-Gangliosidosis Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The HEXB Gene GM2-Gangliosidosis Type 2 Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HEXB gene, which are responsible for the development of GM2-Gangliosidosis Type 2, also known as Sandhoff disease. This condition is a rare, inherited disorder characterized by the progressive destruction of nerve cells in the brain and spinal cord. The test aims to provide crucial information for early diagnosis and management of the disease, potentially guiding treatment options and genetic counseling for affected families.

Performed using a sample of the patient’s blood or saliva, the test examines the HEXB gene for specific mutations that lead to the enzyme deficiencies characteristic of Sandhoff disease. These enzyme deficiencies result in the accumulation of harmful substances, leading to the symptoms associated with the disorder.

The cost of the HEXB Gene GM2-Gangliosidosis Type 2 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the condition and the specialized nature of the test, this price reflects the advanced technology and expertise required to accurately identify the genetic mutations associated with the disease. Patients seeking this test can expect a high level of accuracy and comprehensive support from DNA Labs UAE, making it a valuable resource for families facing the challenges of GM2-Gangliosidosis Type 2.

Description

HEXB Gene GM2-gangliosidosis type 2 Genetic Test

Test Name: HEXB Gene GM2-gangliosidosis type 2 Genetic Test

Components: HEXB gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for HEXB Gene GM2-gangliosidosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GM2-gangliosidosis type 2.

Test Details:

HEXB gene GM2-gangliosidosis type 2 NGS genetic test is a genetic test that examines the HEXB gene for mutations associated with GM2-gangliosidosis type 2. GM2-gangliosidosis type 2 is a rare genetic disorder that affects the central nervous system. It is caused by mutations in the HEXB gene, which provides instructions for producing an enzyme called beta-hexosaminidase B. This enzyme is involved in breaking down a fatty substance called GM2 ganglioside.

The NGS (Next-Generation Sequencing) genetic test uses advanced sequencing technology to analyze the HEXB gene for any mutations or changes. By identifying these mutations, the test can confirm a diagnosis of GM2-gangliosidosis type 2 or determine the carrier status of an individual.

This genetic test can be useful for individuals with symptoms suggestive of GM2-gangliosidosis type 2, as well as for family members of affected individuals who may be at risk of carrying the mutation. The test results can help with genetic counseling, family planning, and potentially guide treatment options.

It is important to note that this is a specific genetic test for GM2-gangliosidosis type 2 and focuses on the HEXB gene. There are other types of GM2-gangliosidosis caused by mutations in different genes, and separate genetic tests may be required to diagnose those conditions.

Test Name	HEXB Gene GM2-gangliosidosis type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for HEXB Gene GM2-gangliosidosis type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GM2-gangliosidosis type 2
Test Details	HEXB gene GM2-gangliosidosis type 2 NGS genetic test is a genetic test that examines the HEXB gene for mutations associated with GM2-gangliosidosis type 2. GM2-gangliosidosis type 2 is a rare genetic disorder that affects the central nervous system. It is caused by mutations in the HEXB gene, which provides instructions for producing an enzyme called beta-hexosaminidase B. This enzyme is involved in breaking down a fatty substance called GM2 ganglioside. The NGS (Next-Generation Sequencing) genetic test uses advanced sequencing technology to analyze the HEXB gene for any mutations or changes. By identifying these mutations, the test can confirm a diagnosis of GM2-gangliosidosis type 2 or determine the carrier status of an individual. This genetic test can be useful for individuals with symptoms suggestive of GM2-gangliosidosis type 2, as well as for family members of affected individuals who may be at risk of carrying the mutation. The test results can help with genetic counseling, family planning, and potentially guide treatment options. It is important to note that this is a specific genetic test for GM2-gangliosidosis type 2 and focuses on the HEXB gene. There are other types of GM2-gangliosidosis caused by mutations in different genes, and separate genetic tests may be required to diagnose those conditions.